2019
-
-
Jun 27, 2019 corporate
-
-
corporate
-
Notice Regarding Executive Appointment of a Subsidiary(65 KB)
-
-
Jun 27, 2019 corporate
-
-
corporate
-
Notice Regarding Change of Representative Directors of a subsidiary(59 KB)
-
-
Jun 14, 2019 product/service
-
-
product/service
-
Notice Regarding Launch of 1 Ingredient / 4 Products of Generic Drugs for KYOSOMIRAI PHARMA(65 KB)
-
-
May 09, 2019 stock
-
-
stock
-
Announcement about the Adjustment of the Conversion Value for Euro-Yen Denominated Convertible Bonds Maturing in 2019(12 KB)
-
-
May 09, 2019 performance
-
-
performance
-
Summary of Consolidated Financial Results of Fiscal Year Ended March 31, 2019(455 KB)
-
-
Apr 24, 2019 performance
-
-
performance
-
Notice Regarding Revision of the Full-year Earnings Forecasts for Fiscal Year Ended March 2019(21 KB)
-
-
Apr 01, 2019 other
-
-
other
-
Notice of the Establishment of a Joint Company for Generic Drugs between TOHO HOLDINGS CO., LTD. and SUZUKEN CO., LTD.(93 KB)
-
-
Mar 28, 2019 product/service
-
-
product/service
-
Notice Regarding the Transfer of Marketing Approvals for 11 Ingredients / 28 Products of Generic Drugs for KYOSOMIRAI PHARMA(130 KB)
-
-
Feb 18, 2019 M&A/partnership
-
-
M&A/partnership
-
Notice of Collaboration with SUZUKEN CO., LTD.(69 KB)
-
-
Feb 15, 2019 product/service
-
-
product/service
-
Notice Regarding Marketing Approvals for 1 Ingredient / 4 Products of Generic Drugs for KYOSOMIRAI PHARMA(65 KB)
-
-
Feb 01, 2019 performance
-
-
performance
-
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2019(293 KB)
-
-
Feb 01, 2019 product/service
-
-
product/service
-
Notice Regarding the Transfer of Marketing Approvals and Sales Rights of 27 Ingredients / 56 Products of Generic Drugs for KYOSOMIRAI PHARMA(101 KB)
-
-
Jan 07, 2019 product/service
-
-
product/service
-
Notice Regarding the Transfer of Sales Right of 1 Ingredient / 1 Product of Generic Drug for KYOSOMIRAI PHARMA(47 KB)
